SCNX Overview

Company Profile

Related stocks

APOTEA.ST • Sweden

Apotea AB

85 SEK

885.13M USD 1Y -6.9%

3391.T • Japan

TSURUHA HOLDINGS INC

2,123.5 JPY

6.09B USD 1Y -13.5%

GMRS • United States

GMR Solutions Inc.

10.38 USD

560.75M USD

CBIO • United States

Crescent Biopharma, Inc.

14.91 USD

553.86M USD 1Y +17.1%

SGP • United States

SpyGlass Pharma, Inc.

24.92 USD

833.52M USD

CBLL • United States

CeriBell, Inc.

23.63 USD

906.87M USD 1Y +89.1%

MDLN • United States

Medline Inc.

36.26 USD

48.79B USD

CAI • United States

Caris Life Sciences, Inc.

29.7 USD

8.39B USD 1Y -16.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

United States

Region

North America

Sector

Healthcare

Industry

Pharmaceutical Retailers

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

218.4% p.a.

Max Drawdown (5Y)

-99.8%

Sharpe Ratio (5Y)

-0.34

Beta Factor

4.08

Size Class

Micro Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

High market risk: Beta of 4.08 indicates above-average volatility compared to the broader market.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Elevated Short-Term Volatility: 3Y volatility (257.1%) is noticeably higher than the 5Y average (218.4%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (218.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -99.9% in the extended horizon.